Adults taking tirzepatide lose an average of 15 kilograms over six months while experiencing a 35% reduction in fat mass and preserving skeletal muscle. A study published in the Journal of Diabetes and Its Complications tracked 122 overweight and obese patients in Palermo, Italy, to measure real-world changes in body composition and metabolic health. Patient … Read more
Highlight Therapeutics announced positive Phase 2b results for its investigational intralesional basal cell carcinoma treatment, BO-112, at the European Academy of Dermatology and Venereology Congress in Vienna. The study met its primary endpoint of visual and pathological response at week 24 in patients with resectable primary low- and high-risk forms of the disease. Phase 2b … Read more
A new wearable wrist device developed by University of Massachusetts Amherst researchers uses a machine-learning algorithm to continuously track arm movement impairment in stroke patients. The technology allows clinicians to measure motor severity outside the clinic and make real-time adjustments to therapy programs, shifting rehabilitation away from the current one-size-fits-all standard. Continuous Monitoring Replaces Traditional … Read more
An estimated 3.5 million people are now living with and beyond cancer in the United Kingdom, driven by advances in early diagnosis and treatment. However, finishing medical intervention does not automatically mean returning to life as it was before the disease, as many survivors face persistent fatigue, fear of recurrence, emotional distress, and loss of … Read more
Low-dose radiation therapy significantly reduces long-term disability and structural joint damage in early knee osteoarthritis patients, according to an integrated analysis of a 12-year randomized trial presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting. Researchers tracked 292 participants and found that those treated with 4.5 Gy of radiation alongside standard medications experienced … Read more
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new clinical trial findings and research at the American Society for Radiation Oncology (ASTRO) Annual Meeting, detailing advances in personalized radiation therapy, genetic risk testing, and targeted radioligand treatments for prostate, bile duct, and head and neck cancers. According to UCLA Health, … Read more
Virtual reality headsets displaying flowing rivers and forests, paired with classical compositions by Bach and Mozart, can significantly lower blood pressure within 15 minutes of an emergency department visit, according to a randomized controlled trial presented at the European Emergency Medicine Congress. Researchers found that this non-pharmacological approach effectively curtails acute anxiety and rapidly reduces … Read more
Robotic seals, conversational AI prompters, and interactive machines are actively being tested on elderly patients at Paris’ Broca Hospital to explore how automation can assist with cognitive stimulation and dementia care. Researchers at the facility are examining whether devices like the NAO robot, the Paro robotic seal, and the Miroki interactive robot can effectively support … Read more
Ovarian cancer is frequently diagnosed after the disease has already spread to other parts of the body, leaving patients with a five-year survival rate of under 30 percent, according to researchers at the University of Maryland, Baltimore County (UMBC). Standard therapies often inflict heavy damage on healthy cells alongside malignant cells. New research published September … Read more
Baseline Liver Fibrosis Severity Predicts Hepatitis B Treatment Response Baseline liver fibrosis severity acts as a key independent factor in predicting treatment response to pegylated interferon-alpha combined with nucleos(t)ide analogs in patients with hepatitis B e antigen-positive chronic hepatitis B, according to a study published in the Journal of Clinical and Translational Hepatology. Researchers at … Read more